» Articles » PMID: 8304312

Radiological Study of Idiopathic Budd-Chiari Syndrome Complicated by Hepatocellular Carcinoma. A Report of Four Cases

Overview
Specialty Gastroenterology
Date 1994 Feb 1
PMID 8304312
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

During an 11-yr period (1979-1989), we have experienced five patients with idiopathic Budd-Chiari syndrome (BCS), four (80%) of whom had associated hepatocellular carcinoma (HCC). In contrast, the incidence of BCS complicated by HCC was 0.7% of a total of 556 patients who underwent surgery for HCC or were autopsied. Hepatitis B virus-related antigen or antibody was positive in one patient each. Four of our five patients were asymptomatic and were initially diagnosed by ultrasonography (n = 3) or computed tomography (n = 1). The hepatic parenchyma histopathological findings were cirrhosis and fibrosis in one each. Infection of hepatitis B virus rather than BCS was speculated as a causative factor for HCC in two patients. Membranous obstruction with spotty calcification, intrahepatic bizarre communicating vessels, and the dilated anterior longitudinal veins in spinal canal were recognized in three patients. Three patients had two HCCs which were similar in size and arose from the right and left hepatic lobe, separately, suggesting multicentricity of HCC. Both percutaneous transluminal angioplasty with Gruntzig balloon catheters for the obstruction of the inferior vena cava and hepatic arterial embolization for HCC(s) were performed in three patients. These patients survived 29.3 months on average after the diagnosis of BCS complicated by HCC(s). The opened IVC was confirmed to be patent on an average of 26.3 months after the first angioplasty.

Citing Articles

Focal Liver Lesions in Budd-Chiari Syndrome: Spectrum of Imaging Findings.

Rizzetto F, Rutanni D, Carbonaro L, Vanzulli A Diagnostics (Basel). 2023; 13(14).

PMID: 37510090 PMC: 10378170. DOI: 10.3390/diagnostics13142346.


Budd-Chiari Syndrome Imaging Diagnosis: State of the Art and Future Perspectives.

Porrello G, Mamone G, Miraglia R Diagnostics (Basel). 2023; 13(13).

PMID: 37443650 PMC: 10341099. DOI: 10.3390/diagnostics13132256.


Liver Transplantation for Budd-Chiari Syndrome in the MELD Era.

Alqahtani S, Schneider C, Sims O, Gurakar A, Tamim H, Bonder A Transplant Direct. 2022; 8(12):e1407.

PMID: 36398192 PMC: 9666155. DOI: 10.1097/TXD.0000000000001407.


Budd-Chiari syndrome: imaging review.

Bansal V, Gupta P, Sinha S, Dhaka N, Kalra N, Vijayvergiya R Br J Radiol. 2018; 91(1092):20180441.

PMID: 30004805 PMC: 6319835. DOI: 10.1259/bjr.20180441.


Studies on Budd-chiari syndrome complicated with hepatocellular carcinoma: most patients without inferior vena cava obstruction.

Dang X, Li L, Li S, Wang Y, Li H, Xu S Int J Clin Exp Med. 2015; 8(6):9071-8.

PMID: 26309561 PMC: 4537987.